A Pilot Phase II Study Evaluating the Role of Chlorine Dioxide on Mucositis for Patients Undergoing Head and Neck Radiotherapy
This is a study to test an over the counter agent to decrease the incidence and severity of mucositis for patients undergoing radiation therapy or radiation therapy and chemotherapy for head and neck cancer
Study phase: II
Basic eligibility criteria:
Please contact the study coordinator for additional eligibility information.
Must be 18 years of age or older and will be undergoing radiation therapy for the treatment of head and neck cancer
Primary disease category: Cancer
Sponsor: Rowpar Pharmaceuticals
Projected enrollment dates: April 2017 to April 2019
Official study title: A Pilot Phase II Study Evaluating the Role of Chlorine Dioxide on Mucositis for Patients Undergoing Head and Neck Radiotherapy